Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation Research
Search: search_blue_button Advanced Search
« Previous Article | Table of Contents | Next Article »
Circulation Research. 2000;87:992-998

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Data Supplement
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Yu, Z.
Right arrow Articles by Kroetz, D. L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Yu, Z.
Right arrow Articles by Kroetz, D. L.
Related Collections
Right arrow Cardiovascular Pharmacology
Right arrow Animal models of human disease
Right arrow Gene expression
Right arrow Hypertension - basic studies
(Circulation Research. 2000;87:992.)
© 2000 American Heart Association, Inc.

Molecular Medicine

Soluble Epoxide Hydrolase Regulates Hydrolysis of Vasoactive Epoxyeicosatrienoic Acids

Zhigang Yu, Fengyun Xu, Linn M. Huse, Christophe Morisseau, Alison J. Draper, John W. Newman, Carol Parker, LeRae Graham, Marguerite M. Engler, Bruce D. Hammock, Darryl C. Zeldin, Deanna L. Kroetz

From the Department of Biopharmaceutical Sciences (Z.Y., F.X., L.M.H., D.L.K.), School of Pharmacy, and Department of Physiological Nursing (M.M.E.), School of Nursing, University of California, San Francisco, Calif; Department of Entomology (C.M., A.J.D., J.W.N., B.D.H.), University of California, Davis, Calif; and the Division of Intramural Research (C.P., L.G., D.C.Z.), National Institute of Environmental Health Sciences, National Institutes of Health, Research Triangle Park, NC.

Correspondence to Deanna L. Kroetz, PhD, Department of Biopharmaceutical Sciences, 513 Parnassus Box 0446, San Francisco, CA 94143-0446. E-mail deanna{at}itsa.ucsf.edu

Abstract—The cytochrome P450-derived epoxyeicosatrienoic acids (EETs) have potent effects on renal vascular reactivity and tubular sodium and water transport; however, the role of these eicosanoids in the pathogenesis of hypertension is controversial. The current study examined the hydrolysis of the EETs to the corresponding dihydroxyeicosatrienoic acids (DHETs) as a mechanism for regulation of EET activity and blood pressure. EET hydrolysis was increased 5- to 54-fold in renal cortical S9 fractions from the spontaneously hypertensive rat (SHR) relative to the normotensive Wistar-Kyoto (WKY) rat. This increase was most significant for the 14,15-EET regioisomer, and there was a clear preference for hydrolysis of 14,15-EET over the 8,9- and 11,12-EETs. Increased EET hydrolysis was consistent with increased expression of soluble epoxide hydrolase (sEH) in the SHR renal microsomes and cytosol relative to the WKY samples. The urinary excretion of 14,15-DHET was 2.6-fold higher in the SHR than in the WKY rat, confirming increased EET hydrolysis in the SHR in vivo. Blood pressure was decreased 22±4 mm Hg (P<0.01) 6 hours after treatment of SHRs with the selective sEH inhibitor N,N'-dicyclohexylurea; this treatment had no effect on blood pressure in the WKY rat. These studies identify sEH as a novel therapeutic target for control of blood pressure. The identification of a potent and selective inhibitor of EET hydrolysis will be invaluable in separating the vascular effects of the EET and DHET eicosanoids.


Key Words: epoxyeicosatrienoic acids • dihydroxyeicosatrienoic acids • cytochrome P450 • soluble epoxide hydrolase • hypertension




This article has been cited by other articles:


Home page
 BloodHome page
S. Y. Cheranov, M. Karpurapu, D. Wang, B. Zhang, R. C. Venema, and G. N. Rao
An essential role for SRC-activated STAT-3 in 14,15-EET-induced VEGF expression and angiogenesis
Blood, June 15, 2008; 111(12): 5581 - 5591.
[Abstract] [Full Text] [PDF]

Home page
 HypertensionHome page
P. Minuz, H. Jiang, C. Fava, L. Turolo, S. Tacconelli, M. Ricci, P. Patrignani, A. Morganti, A. Lechi, and J. C. McGiff
Altered Release of Cytochrome P450 Metabolites of Arachidonic Acid in Renovascular Disease
Hypertension, May 1, 2008; 51(5): 1379 - 1385.
[Abstract] [Full Text] [PDF]

Home page
 Arterioscler. Thromb. Vasc. Bio.Home page
I. Fleming, A. Rueben, R. Popp, B. Fisslthaler, S. Schrodt, A. Sander, J. Haendeler, J. R. Falck, C. Morisseau, B. D. Hammock, et al.
Epoxyeicosatrienoic Acids Regulate Trp Channel Dependent Ca2+ Signaling and Hyperpolarization in Endothelial Cells
Arterioscler. Thromb. Vasc. Biol., December 1, 2007; 27(12): 2612 - 2618.
[Abstract] [Full Text] [PDF]

Home page
 Mol Hum ReprodHome page
G. Irusta, M.J. Murphy, W.D. Perez, and J.D. Hennebold
Dynamic expression of epoxyeicosatrienoic acid synthesizing and metabolizing enzymes in the primate corpus luteum
Mol. Hum. Reprod., August 1, 2007; 13(8): 541 - 548.
[Abstract] [Full Text] [PDF]

Home page
 Drug Metab. Dispos.Home page
V. Y. Ng, Y. Huang, L. M. Reddy, J. R. Falck, E. T. Lin, and D. L. Kroetz
Cytochrome P450 Eicosanoids are Activators of Peroxisome Proliferator-Activated Receptor {alpha}
Drug Metab. Dispos., July 1, 2007; 35(7): 1126 - 1134.
[Abstract] [Full Text] [PDF]

Home page
 Proc. Natl. Acad. Sci. USAHome page
D. Ai, Y. Fu, D. Guo, H. Tanaka, N. Wang, C. Tang, B. D. Hammock, J. Y.-J. Shyy, and Y. Zhu
Angiotensin II up-regulates soluble epoxide hydrolase in vascular endothelium in vitro and in vivo
PNAS, May 22, 2007; 104(21): 9018 - 9023.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Cell Physiol.Home page
A. A. Spector and A. W. Norris
Action of epoxyeicosatrienoic acids on cellular function
Am J Physiol Cell Physiol, March 1, 2007; 292(3): C996 - C1012.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
A. Luria, S. M. Weldon, A. K. Kabcenell, R. H. Ingraham, D. Matera, H. Jiang, R. Gill, C. Morisseau, J. W. Newman, and B. D. Hammock
Compensatory Mechanism for Homeostatic Blood Pressure Regulation in Ephx2 Gene-disrupted Mice
J. Biol. Chem., February 2, 2007; 282(5): 2891 - 2898.
[Abstract] [Full Text] [PDF]

Home page
 Proc. Natl. Acad. Sci. USAHome page
D. Xu, N. Li, Y. He, V. Timofeyev, L. Lu, H.-J. Tsai, I.-H. Kim, D. Tuteja, R. K. P. Mateo, A. Singapuri, et al.
Prevention and reversal of cardiac hypertrophy by soluble epoxide hydrolase inhibitors
PNAS, December 5, 2006; 103(49): 18733 - 18738.
[Abstract] [Full Text] [PDF]

Home page
 Arterioscler. Thromb. Vasc. Bio.Home page
V. Y. Ng, C. Morisseau, J. R. Falck, B. D. Hammock, and D. L. Kroetz
Inhibition of Smooth Muscle Proliferation by Urea-Based Alkanoic Acids via Peroxisome Proliferator-Activated Receptor {alpha}-Dependent Repression of Cyclin D1
Arterioscler. Thromb. Vasc. Biol., November 1, 2006; 26(11): 2462 - 2468.
[Abstract] [Full Text] [PDF]

Home page
 J. Pharmacol. Exp. Ther.Home page
J. J. Olearczyk, M. B. Field, I.-H. Kim, C. Morisseau, B. D. Hammock, and J. D. Imig
Substituted Adamantyl-Urea Inhibitors of the Soluble Epoxide Hydrolase Dilate Mesenteric Resistance Vessels
J. Pharmacol. Exp. Ther., September 1, 2006; 318(3): 1307 - 1314.
[Abstract] [Full Text] [PDF]

Home page
 Hum Mol GenetHome page
C. R. Lee, K. E. North, M. S. Bray, M. Fornage, J. M. Seubert, J. W. Newman, B. D. Hammock, D. J. Couper, G. Heiss, and D. C. Zeldin
Genetic variation in soluble epoxide hydrolase (EPHX2) and risk of coronary heart disease: The Atherosclerosis Risk in Communities (ARIC) study
Hum. Mol. Genet., May 15, 2006; 15(10): 1640 - 1649.
[Abstract] [Full Text] [PDF]

Home page
 J. Pharmacol. Exp. Ther.Home page
Z. Yu, V. Y. Ng, P. Su, M. M. Engler, M. B. Engler, Y. Huang, E. Lin, and D. L. Kroetz
Induction of Renal Cytochrome P450 Arachidonic Acid Epoxygenase Activity by Dietary {gamma}-Linolenic Acid
J. Pharmacol. Exp. Ther., May 1, 2006; 317(2): 732 - 738.
[Abstract] [Full Text] [PDF]

Home page
 HypertensionHome page
I. Fleming and R. Busse
Endothelium-Derived Epoxyeicosatrienoic Acids and Vascular Function
Hypertension, April 1, 2006; 47(4): 629 - 633.
[Abstract] [Full Text] [PDF]

Home page
 HypertensionHome page
A. A. Elmarakby, J. E. Quigley, D. M. Pollock, and J. D. Imig
Tumor Necrosis Factor {alpha} Blockade Increases Renal Cyp2c23 Expression and Slows the Progression of Renal Damage in Salt-Sensitive Hypertension
Hypertension, March 1, 2006; 47(3): 557 - 562.
[Abstract] [Full Text] [PDF]

Home page
 J. Pharmacol. Exp. Ther.Home page
B. B. Davis, C. Morisseau, J. W. Newman, T. L. Pedersen, B. D. Hammock, and R. H. Weiss
Attenuation of Vascular Smooth Muscle Cell Proliferation by 1-Cyclohexyl-3-dodecyl Urea Is Independent of Soluble Epoxide Hydrolase Inhibition
J. Pharmacol. Exp. Ther., February 1, 2006; 316(2): 815 - 821.
[Abstract] [Full Text] [PDF]

Home page
 Circ. Res.Home page
J. Vriens, G. Owsianik, B. Fisslthaler, M. Suzuki, A. Janssens, T. Voets, C. Morisseau, B.D. Hammock, I. Fleming, R. Busse, et al.
Modulation of the Ca2 Permeable Cation Channel TRPV4 by Cytochrome P450 Epoxygenases in Vascular Endothelium
Circ. Res., October 28, 2005; 97(9): 908 - 915.
[Abstract] [Full Text] [PDF]

Home page
 HypertensionHome page
J. D. Imig, X. Zhao, C. Z. Zaharis, J. J. Olearczyk, D. M. Pollock, J. W. Newman, I.-H. Kim, T. Watanabe, and B. D. Hammock
An Orally Active Epoxide Hydrolase Inhibitor Lowers Blood Pressure and Provides Renal Protection in Salt-Sensitive Hypertension
Hypertension, October 1, 2005; 46(4): 975 - 981.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Renal Physiol.Home page
J. D. Imig
Epoxide hydrolase and epoxygenase metabolites as therapeutic targets for renal diseases
Am J Physiol Renal Physiol, September 1, 2005; 289(3): F496 - F503.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Renal Physiol.Home page
J. M. Seubert, F. Xu, J. P. Graves, J. B. Collins, S. O. Sieber, R. S. Paules, D. L. Kroetz, and D. C. Zeldin
Differential renal gene expression in prehypertensive and hypertensive spontaneously hypertensive rats
Am J Physiol Renal Physiol, September 1, 2005; 289(3): F552 - F561.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Renal Physiol.Home page
E. L. Liclican, J. C. McGiff, P. L. Pedraza, N. R. Ferreri, J. R. Falck, and M. A. Carroll
Exaggerated response to adenosine in kidneys from high salt-fed rats: role of epoxyeicosatrienoic acids
Am J Physiol Renal Physiol, August 1, 2005; 289(2): F386 - F392.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
A. Pozzi, I. Macias-Perez, T. Abair, S. Wei, Y. Su, R. Zent, J. R. Falck, and J. H. Capdevila
Characterization of 5,6- and 8,9-Epoxyeicosatrienoic Acids (5,6- and 8,9-EET) as Potent in Vivo Angiogenic Lipids
J. Biol. Chem., July 22, 2005; 280(29): 27138 - 27146.
[Abstract] [Full Text] [PDF]

Home page
 J. Pharmacol. Exp. Ther.Home page
X. Fang, S. Hu, T. Watanabe, N. L. Weintraub, G. D. Snyder, J. Yao, Y. Liu, J. Y.-J. Shyy, B. D. Hammock, and A. A. Spector
Activation of Peroxisome Proliferator-Activated Receptor {alpha} by Substituted Urea-Derived Soluble Epoxide Hydrolase Inhibitors
J. Pharmacol. Exp. Ther., July 1, 2005; 314(1): 260 - 270.
[Abstract] [Full Text] [PDF]

Home page
 HypertensionHome page
O. Jung, R. P. Brandes, I.-H. Kim, F. Schweda, R. Schmidt, B. D. Hammock, R. Busse, and I. Fleming
Soluble Epoxide Hydrolase Is a Main Effector of Angiotensin II-Induced Hypertension
Hypertension, April 1, 2005; 45(4): 759 - 765.
[Abstract] [Full Text] [PDF]

Home page
 Proc. Natl. Acad. Sci. USAHome page
K. R. Smith, K. E. Pinkerton, T. Watanabe, T. L. Pedersen, S. J. Ma, and B. D. Hammock
Attenuation of tobacco smoke-induced lung inflammation by treatment with a soluble epoxide hydrolase inhibitor
PNAS, February 8, 2005; 102(6): 2186 - 2191.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Renal Physiol.Home page
Y. Zhou, H.-H. Chang, J. Du, C.-Y. Wang, Z. Dong, and M.-H. Wang
Renal epoxyeicosatrienoic acid synthesis during pregnancy
Am J Physiol Renal Physiol, January 1, 2005; 288(1): F221 - F226.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Heart Circ. Physiol.Home page
X. Fang, N. L. Weintraub, R. B. McCaw, S. Hu, S. D. Harmon, J. B. Rice, B. D. Hammock, and A. A. Spector
Effect of soluble epoxide hydrolase inhibition on epoxyeicosatrienoic acid metabolism in human blood vessels
Am J Physiol Heart Circ Physiol, December 1, 2004; 287(6): H2412 - H2420.
[Abstract] [Full Text] [PDF]

Home page
 EndocrinologyHome page
J. W. Newman, J. E. Stok, J. D. Vidal, C. J. Corbin, Q. Huang, B. D. Hammock, and A. J. Conley
Cytochrome P450-Dependent Lipid Metabolism in Preovulatory Follicles
Endocrinology, November 1, 2004; 145(11): 5097 - 5105.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
H. Jiang, J. C. McGiff, J. Quilley, D. Sacerdoti, L. M. Reddy, J. R. Falck, F. Zhang, K. M. Lerea, and P. Y-K Wong
Identification of 5,6-trans-Epoxyeicosatrienoic Acid in the Phospholipids of Red Blood Cells
J. Biol. Chem., August 27, 2004; 279(35): 36412 - 36418.
[Abstract] [Full Text] [PDF]

Home page
 Endocr. Rev.Home page
T. M. Doherty, L. A. Fitzpatrick, D. Inoue, J.-H. Qiao, M. C. Fishbein, R. C. Detrano, P. K. Shah, and T. B. Rajavashisth
Molecular, Endocrine, and Genetic Mechanisms of Arterial Calcification
Endocr. Rev., August 1, 2004; 25(4): 629 - 672.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
E. A. Dos Santos, A. J. Dahly-Vernon, K. M. Hoagland, and R. J. Roman
Inhibition of the formation of EETs and 20-HETE with 1-aminobenzotriazole attenuates pressure natriuresis
Am J Physiol Regulatory Integrative Comp Physiol, July 1, 2004; 287(1): R58 - R68.
[Abstract] [Full Text] [PDF]

Home page
 J. Am. Soc. Nephrol.Home page
X. Zhao, T. Yamamoto, J. W. Newman, I.-H. Kim, T. Watanabe, B. D. Hammock, J. Stewart, J. S. Pollock, D. M. Pollock, and J. D. Imig
Soluble Epoxide Hydrolase Inhibition Protects the Kidney from Hypertension-Induced Damage
J. Am. Soc. Nephrol., May 1, 2004; 15(5): 1244 - 1253.
[Abstract] [Full Text] [PDF]

Home page
 J. Histochem. Cytochem.Home page
A. E. Enayetallah, R. A. French, M. S. Thibodeau, and D. F. Grant
Distribution of Soluble Epoxide Hydrolase and of Cytochrome P450 2C8, 2C9, and 2J2 in Human Tissues
J. Histochem. Cytochem., April 1, 2004; 52(4): 447 - 454.
[Abstract] [Full Text] [PDF]

Home page
 Toxicol SciHome page
S. B. DuTeaux, J. W. Newman, C. Morisseau, E. A. Fairbairn, K. Jelks, B. D. Hammock, and M. G. Miller
Epoxide Hydrolases in the Rat Epididymis: Possible Roles in Xenobiotic and Endogenous Fatty Acid Metabolism
Toxicol. Sci., April 1, 2004; 78(2): 187 - 195.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Renal Physiol.Home page
Z. Yu, B. B. Davis, C. Morisseau, B. D. Hammock, J. L. Olson, D. L. Kroetz, and R. H. Weiss
Vascular localization of soluble epoxide hydrolase in the human kidney
Am J Physiol Renal Physiol, April 1, 2004; 286(4): F720 - F726.
[Abstract] [Full Text] [PDF]

Home page
 Mol. Pharmacol.Home page
J. Ma, J. Graves, J. A. Bradbury, Y. Zhao, D. L. Swope, L. King, W. Qu, J. Clark, P. Myers, V. Walker, et al.
Regulation of Mouse Renal CYP2J5 Expression by Sex Hormones
Mol. Pharmacol., March 1, 2004; 65(3): 730 - 743.
[Abstract] [Full Text] [PDF]

Home page
 CirculationHome page
M. Fornage, E. Boerwinkle, P. A. Doris, D. Jacobs, K. Liu, and N. D. Wong
Polymorphism of the Soluble Epoxide Hydrolase Is Associated With Coronary Artery Calcification in African-American Subjects: The Coronary Artery Risk Development In Young Adults (CARDIA) Study
Circulation, January 27, 2004; 109(3): 335 - 339.
[Abstract] [Full Text] [PDF]

Home page
 HypertensionHome page
K. M. Hoagland, A. K. Flasch, and R. J. Roman
Inhibitors of 20-HETE Formation Promote Salt-Sensitive Hypertension in Rats
Hypertension, October 1, 2003; 42(4): 669 - 673.
[Abstract] [Full Text] [PDF]

Home page
 HypertensionHome page
S. I. Pomposiello, J. Quilley, M. A. Carroll, J. R. Falck, and J. C. McGiff
5,6-Epoxyeicosatrienoic Acid Mediates the Enhanced Renal Vasodilation to Arachidonic Acid in the SHR
Hypertension, October 1, 2003; 42(4): 548 - 554.
[Abstract] [Full Text] [PDF]

Home page
 Drug Metab. Dispos.Home page
T. Watanabe, C. Morisseau, J. W. Newman, and B. D. Hammock
IN VITRO METABOLISM OF THE MAMMALIAN SOLUBLE EPOXIDE HYDROLASE INHIBITOR, 1-CYCLOHEXYL-3-DODECYL-UREA
Drug Metab. Dispos., July 1, 2003; 31(7): 846 - 853.
[Abstract] [Full Text] [PDF]

Home page
 Proc. Natl. Acad. Sci. USAHome page
A. Cronin, S. Mowbray, H. Durk, S. Homburg, I. Fleming, B. Fisslthaler, F. Oesch, and M. Arand
The N-terminal domain of mammalian soluble epoxide hydrolase is a phosphatase
PNAS, February 18, 2003; 100(4): 1552 - 1557.
[Abstract] [Full Text] [PDF]

Home page
 Proc. Natl. Acad. Sci. USAHome page
J. W. Newman, C. Morisseau, T. R. Harris, and B. D. Hammock
The soluble epoxide hydrolase encoded by EPXH2 is a bifunctional enzyme with novel lipid phosphate phosphatase activity
PNAS, February 18, 2003; 100(4): 1558 - 1563.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Heart Circ. Physiol.Home page
X. Fang, N. L. Weintraub, C. L. Oltman, L. L. Stoll, T. L. Kaduce, S. Harmon, K. C. Dellsperger, C. Morisseau, B. D. Hammock, and A. A. Spector
Human coronary endothelial cells convert 14,15-EET to a biologically active chain-shortened epoxide
Am J Physiol Heart Circ Physiol, December 1, 2002; 283(6): H2306 - H2314.
[Abstract] [Full Text] [PDF]

Home page
 HypertensionHome page
M. Fornage, C. A. Hinojos, B. W. Nurowska, E. Boerwinkle, B. D. Hammock, C. H.P. Morisseau, and P. A. Doris
Polymorphism in Soluble Epoxide Hydrolase and Blood Pressure in Spontaneously Hypertensive Rats
Hypertension, October 1, 2002; 40(4): 485 - 490.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
L. A. Cowart, S. Wei, M.-H. Hsu, E. F. Johnson, M. U. Krishna, J. R. Falck, and J. H. Capdevila
The CYP4A Isoforms Hydroxylate Epoxyeicosatrienoic Acids to Form High Affinity Peroxisome Proliferator-activated Receptor Ligands
J. Biol. Chem., September 13, 2002; 277(38): 35105 - 35112.
[Abstract] [Full Text] [PDF]

Home page
 J. Lipid Res.Home page
J. W. Newman, T. Watanabe, and B. D. Hammock
The simultaneous quantification of cytochrome P450 dependent linoleate and arachidonate metabolites in urine by HPLC-MS/MS
J. Lipid Res., September 1, 2002; 43(9): 1563 - 1578.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
F. Xu, W. O. Straub, W. Pak, P. Su, K. G. Maier, M. Yu, R. J. Roman, P. R. Ortiz De Montellano, and D. L. Kroetz
Antihypertensive effect of mechanism-based inhibition of renal arachidonic acid omega -hydroxylase activity
Am J Physiol Regulatory Integrative Comp Physiol, September 1, 2002; 283(3): R710 - R720.
[Abstract] [Full Text] [PDF]

Home page
 Circ. Res.Home page
I. Fleming
To Move or Not To Move?: Cytochrome P450 Products and Cell Migration
Circ. Res., May 17, 2002; 90(9): 936 - 938.
[Full Text] [PDF]

Home page
 Proc. Natl. Acad. Sci. USAHome page
B. B. Davis, D. A. Thompson, L. L. Howard, C. Morisseau, B. D. Hammock, and R. H. Weiss
Inhibitors of soluble epoxide hydrolase attenuate vascular smooth muscle cell proliferation
PNAS, February 6, 2002; (2002) 261710799.
[Abstract] [Full Text] [PDF]

Home page
 HypertensionHome page
J. D. Imig, X. Zhao, J. H. Capdevila, C. Morisseau, and B. D. Hammock
Soluble Epoxide Hydrolase Inhibition Lowers Arterial Blood Pressure in Angiotensin II Hypertension
Hypertension, February 1, 2002; 39(2): 690 - 694.
[Abstract] [Full Text] [PDF]

Home page
 Physiol. Rev.Home page
R. J. Roman
P-450 Metabolites of Arachidonic Acid in the Control of Cardiovascular Function
Physiol Rev, January 1, 2002; 82(1): 131 - 185.
[Abstract] [Full Text] [PDF]

Home page
 Circ. Res.Home page
I. Fleming
Cytochrome P450 and Vascular Homeostasis
Circ. Res., October 26, 2001; 89(9): 753 - 762.
[Abstract] [Full Text] [PDF]

Home page
 Mol. Pharmacol.Home page
B. Yang, L. Graham, S. Dikalov, R. P. Mason, J. R. Falck, J. K. Liao, and D. C. Zeldin
Overexpression of Cytochrome P450 CYP2J2 Protects against Hypoxia-Reoxygenation Injury in Cultured Bovine Aortic Endothelial Cells
Mol. Pharmacol., August 1, 2001; 60(2): 310 - 320.
[Abstract] [Full Text] [PDF]

Home page
 Nephrol Dial TransplantHome page
I. Fleming and R. Busse
Vascular cytochrome P450 in the regulation of renal function and vascular tone: EDHF, superoxide anions and blood pressure
Nephrol. Dial. Transplant., July 1, 2001; 16(7): 1309 - 1311.
[Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
X. Fang, T. L. Kaduce, N. L. Weintraub, S. Harmon, L. M. Teesch, C. Morisseau, D. A. Thompson, B. D. Hammock, and A. A. Spector
Pathways of Epoxyeicosatrienoic Acid Metabolism in Endothelial Cells. IMPLICATIONS FOR THE VASCULAR EFFECTS OF SOLUBLE EPOXIDE HYDROLASE INHIBITION
J. Biol. Chem., April 27, 2001; 276(18): 14867 - 14874.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
D. C. Zeldin
Epoxygenase Pathways of Arachidonic Acid Metabolism
J. Biol. Chem., September 21, 2001; 276(39): 36059 - 36062.